---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-25-001174"
form_type: "8-K"
ticker: "CNSP"
cik: "0001729427"
company_name: "CNS Pharmaceuticals, Inc."
filed_at: "2025-02-21T23:59:59+00:00"
generated_at: "2026-05-26T07:04:07.852284+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# CNS Pharmaceuticals announces 1-for-50 reverse stock split effective Feb 21, 2025

## Summary
- Reverse stock split at 1-for-50 ratio effective Feb 21, 2025; shares outstanding reduced from ~136.93M to ~2.74M.
- Split intended to increase per-share price to meet Nasdaq minimum bid price listing requirement.
- No fractional shares; stockholders receive cash in lieu of fractional shares based on closing price on effective date.
- Trading symbol remains "CNSP"; new CUSIP 18978H409; par value unchanged at $0.001.

## SEC filing metadata
- accession: 0001683168-25-001174
- form_type: 8-K
- ticker: CNSP
- cik: 0001729427
- company_name: CNS Pharmaceuticals, Inc.
- filed_at: 2025-02-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1729427/000168316825001174/0001683168-25-001174-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1729427/000168316825001174/cns_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-25-001174
- JSON: https://secwatch.observer/filing/0001683168-25-001174.json
- Plain text: https://secwatch.observer/filing/0001683168-25-001174.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.